Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 10.6f

Immunosuppression Use for Maintenance by Regimen

One Year Following Transplantation, 1998 to 2007

Recipients with Intestine Transplants

  Transplant Year
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Transplants 70 73 82 113 107 116 152 178 175 198
Functioning Graft at 1 Year PostTx 34 37 55 69 73 88 113 130 120 139
With Maintenance Use Recorded at 1 Year PostTx 21 36 55 69 70 87 112 130 120 139
CyA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 0.7%
Tac 14.3% 2.8% 3.6% 26.1% 21.4% 39.1% 29.5% 37.7% 33.3% 27.3%
Tac + MMF/MPA 0.0% 0.0% 0.0% 0.0% 0.0% 1.1% 0.0% 1.5% 0.0% 2.9%
Tac + OtherAntimet 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.7% 1.5% 0.0% 0.0%
--- + Siro/Evero 0.0% 0.0% 0.0% 1.4% 1.4% 1.1% 0.9% 0.8% 0.8% 0.0%
Tac + Siro/Evero 0.0% 2.8% 0.0% 1.4% 1.4% 1.1% 4.5% 2.3% 3.3% 0.7%
--- + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 0.0% 0.0%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 0.8% 0.0%
--- + Steroids 0.0% 0.0% 1.8% 0.0% 1.4% 3.4% 1.8% 0.8% 0.0% 1.4%
CyA + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 1.5% 0.8% 0.0%
Tac + Steroids 57.1% 61.1% 61.8% 58.0% 47.1% 41.4% 40.2% 35.4% 46.7% 53.2%
Tac + MMF/MPA + Steroids 23.8% 11.1% 9.1% 2.9% 4.3% 6.9% 6.3% 3.8% 5.0% 5.8%
Tac + OtherAntimet + Steroids 4.8% 11.1% 0.0% 2.9% 0.0% 0.0% 1.8% 1.5% 0.8% 1.4%
--- + Siro/Evero + Steroids 0.0% 0.0% 1.8% 0.0% 0.0% 1.1% 3.6% 0.0% 0.0% 1.4%
Tac + Siro/Evero + Steroids 0.0% 8.3% 21.8% 7.2% 21.4% 4.6% 8.0% 11.5% 7.5% 3.6%
Other Regimen 0.0% 2.8% 0.0% 0.0% 1.4% 0.0% 0.0% 0.0% 0.0% 1.4%


Source: OPTN/SRTR Data as of May 4, 2009.

Percentages are calculated based on the total number of patients with maintenance use at one year following transplantation. They sum to 100 percent for each column.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.



PDF FormatRequires Adobe Acrobat Reader